Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States

Bryan R. Luce, Kristin L. Nichol, Robert B. Belshe, Kevin D. Frick, Su Xia Li, Audra Boscoe, Matthew D. Rousculp, Parthiv J. Mahadevia

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences